biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Support

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 16, 2023 7:39pm

80 Views

Post# 35226831

RE:RE:Support

No, poof. It's not narcissism. It's a signal being sent to Bioasis. 681 signals, sent.

Of course, you believe your own spin but that just makes the shareholder signal that much stronger.

681 thumbs up and I couldn't give a single thumbs up to myself. It's all about shareholder opinion.

Bioasis and you are going to ignore the signal.

Because you all think Bioasis has achieved a NASDAQ listing, has actually acquired Midatech, and it's all because of how great a job Rathjen has done.

Wakie, wakie...

jd

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)